Idera Pharmaceuticals to Participate in Focus Session at BIO CEO & Investor Conference
February 13 2006 - 8:00AM
Business Wire
Idera Pharmaceuticals, Inc. (AMEX: IDP) announced today that Sudhir
Agrawal, D. Phil., Idera's Chief Executive Officer and Chief
Scientific Officer will participate in a Drug Development Focus
Session at the BIO CEO & Investor Conference 2006, taking place
at the Waldorf Astoria Hotel in New York City February 13th through
February 15th. The session, entitled, "Toll-Like Receptors: The
Cure for All Ailments?" will take place at 8:30 am ET on Wednesday,
February 15th in the Basildon Room. Toll-like receptors (TLRs)
function in immune cells as the sensors of pathogens. They
recognize different molecules present in pathogens, such as
bacteria, viruses and parasites, and mount an appropriate immune
response against the foreign invaders. TLRs have become attractive
targets for developing immune modulators to treat a number of
diseases including cancer, asthma, allergies, and infectious
diseases. For more information on the session or the conference,
please visit:
http://ceo.bio.org/opencms/ceo/2006/program/index.jsp. About Idera
Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. (AMEX: IDP) is a
Cambridge, Massachusetts-based biotechnology company focused on the
discovery, development, and commercialization of targeted immune
therapies based on modulation of Toll-like receptors (TLRs), a
class of receptors with broad commercial potential in the areas of
oncology, infectious disease and allergy/asthma. Idera's most
advanced clinical candidate, IMO2055 (or HYB2055), targets TLR9 and
is currently in a Phase 2 monotherapy trial in renal cell
carcinoma, and a Phase 1/2 combination therapy trial in
non-small-cell lung cancer. Idera is collaborating with Novartis on
drug candidates targeting asthma and allergies and has identified
pre-clinical candidates in-house targeting a variety of infectious
diseases. For more information, visit www.iderapharma.com.
Idera Pharmaceutical (AMEX:IDP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Idera Pharmaceutical (AMEX:IDP)
Historical Stock Chart
From Jul 2023 to Jul 2024